Skip to Main Content

Paper Details

Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma.
Clin Cancer Res
6
2022
CD4, CD4+, CD4+ T cell, CD4+ TILs, CD8, CD8+, CD8+ TILs, HLA, HLA class I and II molecules, HLA molecules, RNA, T cell, T cell receptor, TCR, TIL-derived CD4+ T cell clones, TILs, amino acid, amino acids, autologous, cancers, glioblastoma, peripheral blood T cells, tumor, tumor-infiltrating lymphocytes
Author NameAffiliation
Tobias WeissUniversity Hospital Zurich, University of Zurich
Elisabeth J RushingInstitute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich
Catherine J WuDana-Farber Cancer Institute
Catherine J WuBrigham and Women's Hospital
Catherine J WuBroad Institute of MIT and Harvard
Catherine J WuHarvard Medical School
Holger MochInstitute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich
Holger MochInstitute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich
Bernd BodenmillerUniversity of Zurich
Bernd BodenmillerInstitute of Molecular Life Sciences, University of Zurich
Bernd BodenmillerUniversity of Zurich
Bernd BodenmillerInstitute of Molecular Life Sciences, University of Zurich
Michael WellerUniversity Hospital Zurich, University of Zurich
  • 1 - 13

Datasets

Release 1.2